Syncom Formulations (India) Limited Overview
Get informed when a big investor buys or sells
+ Follow21.14
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for SYNCOMF.NS is 21.14. That is below the sector sector average of 24.62. Investors often review this figure alongside Syncom Formulations (India) Limited's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, SYNCOMF.NS currently prints 21.14 for P/E ratio, while the sector average sits near 24.62. That is roughly 14.2% below the sector mean. Large gaps often invite a closer look at Syncom Formulations (India) Limited's growth, margins, and balance sheet.
A P/E ratio of 21.14 for Syncom Formulations (India) Limited is not 'good' or 'bad' on its own. Compare it with the peer average (24.62) and with SYNCOMF.NS's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting SYNCOMF.NS's P/E ratio (21.14), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
